| 000 | 01105 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250515023844.0 | ||
| 264 | 0 | _c20061106 | |
| 008 | 200611s 0 0 eng d | ||
| 022 | _a0920-3206 | ||
| 024 | 7 |
_a10.1007/s10557-006-7297-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFerrari, Roberto | |
| 245 | 0 | 0 |
_aACE-inhibition for secondary prevention of cardiovascular events--should we change our recommendation after PEACE? _h[electronic resource] |
| 260 |
_bCardiovascular drugs and therapy _cFeb 2006 |
||
| 300 |
_a11-2 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Editorial | ||
| 650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xprevention & control |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMeta-Analysis as Topic |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aSecondary Prevention |
| 773 | 0 |
_tCardiovascular drugs and therapy _gvol. 20 _gno. 1 _gp. 11-2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10557-006-7297-8 _zAvailable from publisher's website |
| 999 |
_c16251331 _d16251331 |
||